myeloma {asbio}R Documentation

Patient responses to myeloma drug treatments

Description

Murakami et al. (1997) studied the effect of drugs treatments on levels of serum beta-2 microglobulin in patients with multiple myeloma. Serum beta-2 microglobulin is produced in the body as a result of myelomas, and thus can be used as an indicator of the severity of disease

Usage

data(myeloma)

Format

A data frame with 20 observations on the following 2 variables.

mglobulin

Levels of serum beta-2 microglobulin in mg/l

drug

Drug treatment strategy. Control = sumerifon alone, Trt = malphalan and sumerifon.

Source

Ott, R. L., and M. T. Longnecker (2004) A First Course in Statistical Methods. Thompson.

References

Murakami, H., Ogawara, H., Morita, K., Saitoh, T., Matsushima, T., Tamura, J., Sawamura, M., Karasawa, M., Miyawaki, M.,, Schimano, S., Satoh, S., and J Tsuchiy (1997) Serum beta-2-microglobulin in patients with multiple myeloma treated with alpha interferon. Journal of Medicine 28(5-6):311-8.


[Package asbio version 1.7 Index]